Drug Profile
Research programme: vaccines - Multimeric Biotherapeutics
Alternative Names: Precision Immunization™Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Multimeric Biotherapeutics
- Class Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Smoking withdrawal
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Smoking-withdrawal in USA
- 28 Oct 2011 Preclinical trials in Smoking withdrawal in USA (unspecified route)